Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 1/2024

21.03.2023 | Case Report

A case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma

verfasst von: Akiko Ishigami, Shogo Inaka, Yuko Ishida, Mizuho Nosaka, Yumi Kuninaka, Hiroki Yamamoto, Emi Shimada, Akihiko Kimura, Fukumi Furukawa, Toshikazu Kondo

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

We report a case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma. A 60-year-old female was hospitalized for the treatment of thrombasthenia and cirrhosis caused by chronic Hepatitis C, and computed tomography revealed hepatocellular carcinoma, which was treated by percutaneous radiofrequency ablation. After the ablation, hemoperitoneum was suspected because of the low hemoglobin level with abdominal pain. Approximately 6 h after the ablation treatment, the patient suddenly fell into a shock state and died. In this case, medical treatment-related death including malpractice was suspected, and forensic autopsy was performed. The abdominal cavity contained 910 mL of dark red fluid blood and 210 g of soft hemocoagula. Moreover, several puncture marks were observed on the liver surface and diaphragm, and there was no clear damage to the main arteries and veins. Considering the macroscopic and microscopic findings, the cause of death was assumed as hemorrhagic shock due to the hemoperitoneum caused by the damage to the liver by radiofrequency ablation. It is important to consider all the indications and adverse effects of radiofrequency ablation.
Literatur
1.
Zurück zum Zitat Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16.CrossRefPubMed Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16.CrossRefPubMed
2.
Zurück zum Zitat Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584–96.CrossRefPubMed Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584–96.CrossRefPubMed
3.
Zurück zum Zitat Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol. 2012;47:1125–33.ADSCrossRefPubMed Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol. 2012;47:1125–33.ADSCrossRefPubMed
4.
Zurück zum Zitat Shiina S. Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatol Res. 2007;37:S223–9.CrossRefPubMed Shiina S. Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatol Res. 2007;37:S223–9.CrossRefPubMed
5.
Zurück zum Zitat Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, Du Z. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol. 2013;68:608–15.CrossRefPubMed Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, Du Z. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol. 2013;68:608–15.CrossRefPubMed
6.
Zurück zum Zitat Poggi G, Riccardi A, Quaretti P, Teragni C, Delmonte A, Amatu A, Saini G, Mazzucco M, Bernardo A, Palumbo R, Canto A, Bernieri S, Bernardo G. Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver. Anticancer Res. 2007;27:2911–6.PubMed Poggi G, Riccardi A, Quaretti P, Teragni C, Delmonte A, Amatu A, Saini G, Mazzucco M, Bernardo A, Palumbo R, Canto A, Bernieri S, Bernardo G. Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver. Anticancer Res. 2007;27:2911–6.PubMed
7.
Zurück zum Zitat Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–7.CrossRefPubMed Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–7.CrossRefPubMed
8.
Zurück zum Zitat Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214:761–8.CrossRefPubMed Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214:761–8.CrossRefPubMed
9.
Zurück zum Zitat Casaril A, Abu Hilal M, Harb A, Campagnaro T, Mansueto G, Nicoli N. The safety of radiofrequency thermal ablation in the treatment of liver malignancies. Eur J Surg Oncol. 2008;34:668–72.CrossRefPubMed Casaril A, Abu Hilal M, Harb A, Campagnaro T, Mansueto G, Nicoli N. The safety of radiofrequency thermal ablation in the treatment of liver malignancies. Eur J Surg Oncol. 2008;34:668–72.CrossRefPubMed
10.
Zurück zum Zitat Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16 346 treated nodules in 13 283 patients. Hepatol Res. 2012;42:1058–64.CrossRefPubMed Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16 346 treated nodules in 13 283 patients. Hepatol Res. 2012;42:1058–64.CrossRefPubMed
11.
Zurück zum Zitat Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206–22.CrossRefPubMed Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206–22.CrossRefPubMed
12.
Zurück zum Zitat de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C, Elias D. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol. 2003;181:695–700. de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C, Elias D. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol. 2003;181:695–700.
13.
Zurück zum Zitat Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, Zhang XP, Yin SS. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol. 2005;11:6395–401.CrossRefPubMedPubMedCentral Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, Zhang XP, Yin SS. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol. 2005;11:6395–401.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005;30:409–18.CrossRefPubMed Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005;30:409–18.CrossRefPubMed
15.
Zurück zum Zitat Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Pinna AD. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol. 2013;19:4106–18.CrossRefPubMedPubMedCentral Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Pinna AD. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol. 2013;19:4106–18.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Tombesi P, Di Vece F, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: what’s the first choice? World J Radiol. 2013;5:1–4.CrossRefPubMedPubMedCentral Tombesi P, Di Vece F, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: what’s the first choice? World J Radiol. 2013;5:1–4.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Olaussen A, Blackburn T, Mitra B, Fitzgerald M. Review article: shock index for prediction of critical bleeding post-trauma: a systematic review. Emerg Med Australas. 2014;26:223–8.CrossRefPubMed Olaussen A, Blackburn T, Mitra B, Fitzgerald M. Review article: shock index for prediction of critical bleeding post-trauma: a systematic review. Emerg Med Australas. 2014;26:223–8.CrossRefPubMed
18.
Zurück zum Zitat Aoki Y, Takamiya M, Satoh T, Fujita S, Kato H, Maeno Y. A fatal case of hemoperitoneum after ultrasound-guided liver biopsy in a patient with intravascular large B-cell lymphoma. Leg Med (Tokyo). 2011;13:191–5.CrossRefPubMed Aoki Y, Takamiya M, Satoh T, Fujita S, Kato H, Maeno Y. A fatal case of hemoperitoneum after ultrasound-guided liver biopsy in a patient with intravascular large B-cell lymphoma. Leg Med (Tokyo). 2011;13:191–5.CrossRefPubMed
19.
Zurück zum Zitat Karger B, Varchmin-Schultheiss K, Fechner G. Fatal hepatic haemorrhage in a child-peliosis hepatis versus maltreatment. Int J Legal Med. 2005;119:44–6.CrossRefPubMed Karger B, Varchmin-Schultheiss K, Fechner G. Fatal hepatic haemorrhage in a child-peliosis hepatis versus maltreatment. Int J Legal Med. 2005;119:44–6.CrossRefPubMed
Metadaten
Titel
A case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma
verfasst von
Akiko Ishigami
Shogo Inaka
Yuko Ishida
Mizuho Nosaka
Yumi Kuninaka
Hiroki Yamamoto
Emi Shimada
Akihiko Kimura
Fukumi Furukawa
Toshikazu Kondo
Publikationsdatum
21.03.2023
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 1/2024
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-023-00601-w

Weitere Artikel der Ausgabe 1/2024

Forensic Science, Medicine and Pathology 1/2024 Zur Ausgabe

Neu im Fachgebiet Pathologie